Forte Biosciences Statistics
Total Valuation
FBRX has a market cap or net worth of $587.07 million. The enterprise value is $522.31 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FBRX has 18.77 million shares outstanding. The number of shares has increased by 404.74% in one year.
| Current Share Class | 13.89M |
| Shares Outstanding | 18.77M |
| Shares Change (YoY) | +404.74% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 60.09% |
| Float | 15.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.26 |
| P/TBV Ratio | 9.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.88
| Current Ratio | 3.88 |
| Quick Ratio | 3.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -122.28% and return on invested capital (ROIC) is -77.84%.
| Return on Equity (ROE) | -122.28% |
| Return on Assets (ROA) | -61.19% |
| Return on Invested Capital (ROIC) | -77.84% |
| Return on Capital Employed (ROCE) | -113.91% |
| Weighted Average Cost of Capital (WACC) | 21.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.65M |
| Employee Count | 19 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, FBRX has paid $1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +513.71% in the last 52 weeks. The beta is 3.20, so FBRX's price volatility has been higher than the market average.
| Beta (5Y) | 3.20 |
| 52-Week Price Change | +513.71% |
| 50-Day Moving Average | 28.61 |
| 200-Day Moving Average | 19.42 |
| Relative Strength Index (RSI) | 61.28 |
| Average Volume (20 Days) | 399,920 |
Short Selling Information
The latest short interest is 892,176, so 4.75% of the outstanding shares have been sold short.
| Short Interest | 892,176 |
| Short Previous Month | 727,297 |
| Short % of Shares Out | 4.75% |
| Short % of Float | 5.69% |
| Short Ratio (days to cover) | 3.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.66M |
| Pretax Income | -68.34M |
| Net Income | -69.38M |
| EBITDA | -70.59M |
| EBIT | -70.66M |
| Earnings Per Share (EPS) | -$4.71 |
Full Income StatementBalance Sheet
The company has $76.96 million in cash and n/a in debt, with a net cash position of $76.96 million or $4.10 per share.
| Cash & Cash Equivalents | 76.96M |
| Total Debt | n/a |
| Net Cash | 76.96M |
| Net Cash Per Share | $4.10 |
| Equity (Book Value) | 60.99M |
| Book Value Per Share | 3.42 |
| Working Capital | 59.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.88 million and capital expenditures -$116,000, giving a free cash flow of -$51.00 million.
| Operating Cash Flow | -50.88M |
| Capital Expenditures | -116,000 |
| Depreciation & Amortization | 64,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -51.00M |
| FCF Per Share | -$2.72 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FBRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -404.74% |
| Shareholder Yield | -404.74% |
| Earnings Yield | -11.58% |
| FCF Yield | -8.51% |
Analyst Forecast
The average price target for FBRX is $67.00, which is 114.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.00 |
| Price Target Difference | 114.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 4.05% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 28, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
